Related Experiment Videos
Response of prostate cancer cells to peptide growth factors: transforming growth factor-beta
1University of Wisconsin Clinical Cancer Center, Madison 53792.
Abstract:
The growth of human prostate cancer and its relationship to the surrounding stroma are controlled by complex mechanisms that are incompletely understood. Clearly, peptide growth factors appear to have crucial roles in these processes. One of these factors, TGF-beta, and its family members are notable for their wide spectrum of biological effects. In terms of growth, TGF-beta inhibits the growth of prostate cancer cells in a cytostatic fashion while stimulating the growth of critical stromal cells, such as fibroblasts. Since the inhibitory effects of TGF-beta on prostate cancer cells appear to diminish as the process of transformation progresses towards less differentiated states, the net effect on prostate tumour growth may be positive. Recent evidence suggests that the inhibitory effects of TGF-beta on growth, at least, might be mediated through the RB tumour suppressor gene product and the proto-oncogene c-myc. Beyond its direct growth effects, TGF-beta also alters the response of prostate cancer cells to positive mitogenic factors, such as members of the EGF and FGF families, suggesting that growth control is a delicate balance between positive and negative influences. Non-mitogenic responses to TGF-beta by prostate cancer cells, the immune system, the stroma and the vascular system provide evidence that TGF-beta might also be important in the processes of carcinogenesis, tumour establishment and metastases. In addition, TGF-beta appears to influence metabolic pathways important to drug metabolism and steroidogenesis. In vivo, limited evidence suggests that TGF-beta can alter the growth and differentiation of some tumour types but appears to be very toxic when administered in high doses. A better understanding of the response of prostate cancer cells to members of the TGF-beta family may open new avenues of treating and controlling this disease.
Insights
Transforming growth factor-beta (TGF-β) plays a dual role in prostate cancer, inhibiting cancer cell growth while stimulating stromal cells. Its complex interactions influence tumor progression and may offer new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Prostate cancer growth is complex, involving interactions between cancer cells and the surrounding stroma.
- Peptide growth factors, particularly transforming growth factor-beta (TGF-β) and its family members, are critical regulators of these processes.
- TGF-β exhibits diverse biological effects, including inhibition of prostate cancer cell proliferation and stimulation of stromal cell growth.
Purpose of the Study:
- To elucidate the multifaceted roles of TGF-β in prostate cancer progression.
- To investigate the mechanisms underlying TGF-β's effects on cancer and stromal cells.
- To explore the potential of targeting TGF-β signaling pathways for prostate cancer treatment.
Main Methods:
- Analysis of TGF-β's effects on prostate cancer cell growth and stromal cell proliferation.
- Investigation of TGF-β's influence on cell cycle regulators like RB and c-myc.
- Examination of TGF-β's impact on mitogenic factor responses and non-mitogenic cellular processes.
Main Results:
- TGF-β inhibits prostate cancer cell growth cytostatically but stimulates stromal fibroblast growth.
- Inhibitory effects of TGF-β on cancer cells may decrease with tumor dedifferentiation, potentially promoting tumor growth.
- TGF-β modulates responses to growth factors (EGF, FGF) and influences carcinogenesis, metastasis, drug metabolism, and steroidogenesis.
Conclusions:
- TGF-β has complex, context-dependent effects on prostate cancer, acting as both an inhibitor and promoter of tumor growth.
- Understanding TGF-β signaling in prostate cancer is crucial for developing novel therapeutic strategies.
- Targeting TGF-β family members may offer new avenues for controlling prostate cancer progression and metastasis.